Evaluation of C-reactive protein, procalcitonin, tumor necrosis factor alpha, interleukin-6, and interleukin-8 as diagnostic parameters in sepsis-related fatalities

被引:0
作者
Bettina Schrag
Pascale Roux-Lombard
Deborah Schneiter
Paul Vaucher
Patrice Mangin
Cristian Palmiere
机构
[1] University Centre of Legal Medicine,Division of Immunology and Allergy, Department of Internal Medicine
[2] Lausanne-Geneva,undefined
[3] Geneva University Hospital and University of Geneva,undefined
[4] University Centre of Legal Medicine,undefined
[5] Lausanne-Geneva,undefined
[6] University of Geneva,undefined
来源
International Journal of Legal Medicine | 2012年 / 126卷
关键词
Sepsis; Interleukins; Procalcitonin; C-reactive protein; Postmortem biochemistry;
D O I
暂无
中图分类号
学科分类号
摘要
The aims of this study were to investigate the usefulness of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, interleukin-6, and interleukin-8 as postmortem markers of sepsis and to compare C-reactive protein and procalcitonin values in serum, vitreous humor, and cerebrospinal fluid in a series of sepsis cases and control subjects, in order to determine whether these measurements may be employed for the postmortem diagnosis of sepsis. Two study groups were formed, a sepsis group (eight subjects coming from the intensive care unit of two university hospitals, with a clinical diagnosis of sepsis in vivo) and control group (ten autopsy cases admitted to two university medicolegal centers, deceased from natural and unnatural causes, without elements to presume an underlying sepsis as the cause of death). Serum C-reactive protein and procalcitonin concentrations were significantly different between sepsis cases and control cases, whereas serum tumor necrosis factor alpha, interleukin-6, and interleukin-8 values were not significantly different between the two groups, suggesting that measurement of interleukin-6, interleukin-8, and tumor necrosis factor alpha is non-optimal for postmortem discrimination of cases with sepsis. In the sepsis group, vitreous procalcitonin was detectable in seven out of eight cases. In the control group, vitreous procalcitonin was clearly detectable only in one case, which also showed an increase of all markers in serum and for which the cause of death was myocardial infarction associated with multi-organic failure. According to the results of this study, the determination of vitreous procalcitonin may be an alternative to the serum procalcitonin for the postmortem diagnosis of sepsis.
引用
收藏
页码:505 / 512
页数:7
相关论文
共 82 条
  • [1] Balci C(2003)Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit Crit Care 7 85-90
  • [2] Sungurtekin H(2001)Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis Am J Respir Crit Care Med 164 396-402
  • [3] Gürses E(2009)Macroscopic postmortem findings in 235 surgical intensive care patients with sepsis Anesth Analg 108 1841-1847
  • [4] Sungurtekin U(2001)Serum procalcitonin (PCT): a valuable biochemical parameter for the postmortem diagnosis of sepsis Int J Legal Med 114 237-243
  • [5] Kaptanoglu B(2001)Interleukin-6 and C-reactive protein serum levels in sepsis-related fatalities during the early postmortem period Forensic Sci Int 119 47-56
  • [6] Harbarth S(2000)Immunohistochemical expression of E-selectin in sepsis-induced lung injury Int J Legal Med 113 338-342
  • [7] Holeckova K(2001)Postmortem markers of sepsis: an immunohistochemical study using VLA-4 (CD49d/CD29) and ICAM-1 (CD54) for the detection of sepsis-induced lung injury Int J Legal Med 114 291-294
  • [8] Froidevaux C(2009)Immunohistochemical detection of CCR2 and CX3CR1 in sepsis-induced lung injury Forensic Sci Int 192 21-25
  • [9] Pittet D(2006)Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock Eur J Clin Microbiol Infect Dis 25 481-491
  • [10] Ricou B(1992)Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Crit Care Med 20 864-874